NCT00171782View on ClinicalTrials.gov

Hypertension and Cardiovascular Risk Factors

PHASE4CompletedINTERVENTIONAL

Enrollment

76

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions

HYPERTENSION

Interventions

DRUG

VALSARTAN+HYDROCHLOROTHIAZIDE

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY